AstraZeneca Pharma India Ltd.
BSE
Price on BSE 16 Apr,09:07 LIVE
8,999.80
+128.10
(+1.44%)
© 2025 Rediff.com
- Volume :
- 4.00
- Prev Close :
- 8,871.70
- Day's H/L (Rs.) :
- 8,999.80 - 8,999.80
- 52wk H/L (Rs.) :
- 9,049.95 - 5,000.00
- Mkt Cap (Rs. Cr) :
- 22,499.50
NSE
Price on NSE 16 Apr,09:07 LIVE
8,861.00
-12.50
(-0.14%)
© 2025 Rediff.com
- Volume :
- 86.00
- Prev Close :
- 8,873.50
- Day's H/L (Rs.) :
- 8,861.00 - 0.00
- 52wk H/L (Rs.) :
- 9,059.05 - 4,800.15
- Mkt Cap (Rs. Cr) :
- 0.00
Market News
How Tamil Nadu Is Becoming A Global Hub
Rediff.com 02 Apr 2025
Rediff.com 02 Apr 2025
Mankind Pharma Targets Anti-Obesity Drug
Rediff.com 06 Mar 2025
Rediff.com 06 Mar 2025
Highest Selling New Drug In India Is...
Rediff.com 11 Feb 2025
Rediff.com 11 Feb 2025
Budget Prepares For Rise In Cancer Cases
Rediff.com 03 Feb 2025
Rediff.com 03 Feb 2025
Report Card - AstraZeneca Pharma India Ltd.
PE Ratios
137.16
EPS (Rs.)
64.60
Sales (Rs. Cr)
440.29
Face Value (Rs.)
2
Net Profit Margin(%)
12.46
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
22.68
News for AstraZeneca Pharma India Ltd.
AstraZeneca Surrenders Prostate Cancer Drug Marketing in India
AstraZeneca Pharma India has surrendered marketing authorization for Olaparib (Lynparza) in India due to commercial reasons. The drug is indicated for metastatic castration-resistant prostate cancer.
Apr 15, 2025 13:32AstraZeneca Gets Nod to Import Hyperkalemia Drug Lokelma in India
AstraZeneca Pharma India has received approval to import and sell sodium zirconium cyclosilicate (Lokelma) for treating hyperkalemia in adults in India. The drug is indicated for the treatment of...
Mar 06, 2025 16:46
Andhra CM Meets Bill Gates, Global Execs in Davos
Andhra Pradesh CM N Chandrababu Naidu to meet Bill Gates and global executives at the World Economic Forum in Davos, Switzerland, to discuss investment opportunities and promote 'Brand Andhra'.
Jan 22, 2025 11:03
AI & Machine Learning: Transforming Indian Pharma by 2025
India's pharmaceutical industry is poised for a dramatic transformation by 2025, driven by AI, machine learning, and precision medicine. Discover how innovation, global access, and quality...
Dec 26, 2024 11:20AstraZeneca Gets Approval to Import Lynparza Cancer Drug in India
AstraZeneca Pharma India receives approval to import and distribute Lynparza, an anti-cancer drug, for the treatment of advanced endometrial cancer in India.
Nov 26, 2024 14:30News for Pharmaceuticals and health care
Policybazaar's PB Fintech Gets RBI Payment Aggregator License
PB Fintech, parent company of Policybazaar, secures payment aggregator licence from RBI for its subsidiary PB Pay. The licence allows the company to operate as an online payment aggregator.
Apr 15, 2025 23:24India, Taipei Delay WTO Ruling on ICT Import Duties
India and Chinese Taipei have requested a delay in the WTO's ruling on India's import duties on certain ICT products, aiming to resolve the matter mutually. The WTO dispute settlement body will...
Apr 15, 2025 21:45CCI Approves TPG Growth Funds, AINU Healthcare Deal
The Competition Commission of India (CCI) has approved a deal involving TPG's growth funds, AINU, and other entities. The deal includes investments in healthcare services across India.
Apr 15, 2025 21:45ICICI Lombard Q4 Net Profit Slips 2% to Rs 510 Cr
ICICI Lombard's net profit declined by 2% to Rs 510 crore in Q4 FY25, while total income rose to Rs 5,851 crore. The company also declared a final dividend of Rs 7 per share.
Apr 15, 2025 21:40JSW Steel to Invest Rs 50k Cr for Green Steel in Europe
JSW Steel plans to invest Rs 50,000 crore to build 10 MTPA of green steel capacity in India, targeting the European market. The move is driven by EU green steel mandates and aims to reduce carbon...
Apr 15, 2025 21:38Top News
Policybazaar's PB Fintech Gets RBI Payment Aggregator License
PB Fintech, parent company of Policybazaar, secures payment aggregator licence from RBI for its subsidiary PB Pay. The licence allows the company to operate as an online payment aggregator.
Apr 15, 2025 23:24Lodha Brothers Settle Trademark Dispute: Bombay HC Records Consent Terms
The Bombay High Court has formally recorded the consent terms entered into by Abhishek and Abhinandan Lodha, resolving a trademark dispute between the brothers. The settlement follows mediation...
Apr 15, 2025 23:16Punjab: Pending Mutations, Income Certificates Cleared by Apr 30
Punjab Finance Minister Harpal Singh Cheema announces all pending cases of mutations, income certificates and revenue records inspection will be cleared by April 30. The state government has also...
Apr 15, 2025 22:27India, Taipei Delay WTO Ruling on ICT Import Duties
India and Chinese Taipei have requested a delay in the WTO's ruling on India's import duties on certain ICT products, aiming to resolve the matter mutually. The WTO dispute settlement body will...
Apr 15, 2025 21:45CCI Approves TPG Growth Funds, AINU Healthcare Deal
The Competition Commission of India (CCI) has approved a deal involving TPG's growth funds, AINU, and other entities. The deal includes investments in healthcare services across India.
Apr 15, 2025 21:45